Skip to main content
OpenTrials
Completed

NCT Number: NCT04155957

Evaluation of Safety and Efficacy of ReHub in Patients Who Underwent Primary Total Knee Arthroplasty

This is a randomized, non-blinded, parallel assignment, clinical trial for the evaluation of safety and efficacy of ReHub, a telerehabilitation system made up of a cloud platform and an exercise kit with smart sensors, for performing rehabilitation exercises after a primary Total Knee Arthroplasty.

Primary TKA patients are allocated randomly to the control arm or the experimental arm with a 1:1 ratio. Both arms follow the usual rapid recovery protocol for TKA surgeries at Hospital Clínic de Barcelona, which includes discharge after 2-3 days from the surgery, the prescription of a daily plan of 5 exercises for autonomous rehabilitation and domiciliary visits by a physiotherapist starting approximately 2 weeks after the surgery. The experimental arm participants use ReHub to do their exercises instead of working independently and physiotherapists monitor their performance and adherence remotely.

Outcomes assessment is performed at hospital discharge (baseline), at stitch removal (2 weeks after baseline) and 2 weeks after stitch removal (4 weeks after baseline).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Knee Osteoarthritis Arthritis Joint Diseases Musculoskeletal Diseases Osteoarthritis Osteoarthritis, Knee Rheumatic Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital Clinic of Barcelona

Barcelona, 08036, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Candidates to primary TKA
  • Age from 18 to 75 years old
  • Ability to understand and accept the clinical study procedure and to sign an informed consent form
  • Good predisposition to the use of technology or cohabitation with someone that can give them technological support
  • Availability to attend the Hospital for control visits
  • Patient resides in the area of influence of Hospital Clínic de Barcelona

Exclusion criteria

  • Reluctance or inability to use technology
  • Any type of disability that could alter the homogeneity of the study
  • Sensory and/or cognitive impairment
  • Concomitant medical conditions that may influence the rehabilitation process
  • Any local or systemic complications after TKA surgery (e.g. surgical wound infection, suspicious of deep vein thrombosis)

Treatment and study plan

Rapid Recovery Rehabilitation Programme

Other

Usual intervention at Hospital Clínic de Barcelona for post-operative rehabilitation of TKA patients. Participants, already at home after hospital discharge, must perform 5 different exercises 4 times a day (twice in the morning, twice in the afternoon).

Participants are also encouraged to walk and stretch their legs. Domiciliary visits by a physiotherapist start at approximately 2 weeks after the surgery to help participants do the exercises.

ReHub

Device

Participants use a telerehabilitation platform, ReHub, as a guide to perform the TKA rehabilitation exercises of the Rapid Recovery Rehabilitation Programme intervention.

The exercise plan in ReHub is carried out by a site physiotherapist on the first day after discharge by using ReHub to acquire the participant's movement pattern with a wearable inertial sensor that transmits data to the platform.

The wearable inertial sensor participants must wear tracks movement while they do the TKA rehabilitation exercises. Movement is analysed and feedback is given in real time. At the end of each exercise, participants can select if they have felt pain in a scale from 1 to 10. A physiotherapist monitors the participants' progress remotely.

Primary outcomes

  1. Change in Active Knee Range of Motion (º)

    Time frame: Baseline, 2 weeks and 4 weeks after discharge

    Range of motion of the replaced knee without the aid of the outcomes assessor will be measured with a conventional goniometer.

Secondary outcomes

  1. Change in the Timed Up-and-Go test score (s)

    Time frame: Baseline, 2 weeks and 4 weeks after discharge

    The TUG test outcome is the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.

  2. Change in Self-Reported Pain Level: Visual Analogue Scale

    Time frame: Baseline, 2 weeks and 4 weeks after discharge

    The pain level will be reported by the participant with a Visual Analogue Scale from 0 to 10, with 0 being the absence of pain and 10 being the worst pain imaginable.

  3. Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score

    Time frame: Baseline, 2 weeks and 4 weeks after discharge

    Scores for the WOMAC questionnaire range from 0 to 96, with 0 being the best state and 96 the worst state.

  4. Change in EuroQol-5D-5L (EQ-5D-5L) score

    Time frame: Baseline, 2 weeks and 4 weeks after discharge

    Scores for the EQ-5D-5L questionnaire are 5-digit numbers, each one representing a different aspect of quality of life. Digits can range from 1 to 5. 11111 is considered the ideal state and 55555 the worst state. 9 is used for absent or non-valid answers. The questionnaire also includes a Visual Analogue Scale for indicating perceived self's health state in a scale from 0 (worst state) to 100 (best state).

  5. Change in Quadriceps Strength (kg)

    Time frame: Baseline, 2 weeks and 4 weeks after discharge

    Strength of the quadriceps in the intervened leg will be measured with a dynamometer.

  6. Change in Hamstring Strength (kg)

    Time frame: Baseline, 2 weeks and 4 weeks after discharge

    Strength of the hamstring muscles in the intervened leg will be measured with a dynamometer.

  7. Satisfaction with ReHub: System Usability Scale

    Time frame: 4 weeks after discharge

    Measured with the score from the System Usability Scale questionnaire, which can range from 0 (worst result) to 100 (best result). Only for participants in the experimental arm.

  8. Change in Passive Knee Range of Motion (º)

    Time frame: Baseline, 2 weeks and 4 weeks after discharge

    Range of motion of the replaced knee with the aid of the outcomes assessor will be measured with a conventional goniometer.

Sponsors and collaborators

Lead sponsor

Bio-Sensing Solutions S.L. (DyCare)

Industry

Collaborators

  • EASME
  • Hospital Clinic of Barcelona

Registry information

Acronym: REHAPT

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Nov 7, 2019
Registry last updated
Jun 9, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.